Evidence map›Paper›PMID 29226690›Full record

ArticleAIDS research and human retroviruses2018

Low Levels of Endothelial Progenitor Cells and Their Association with Systemic Inflammation and Monocyte Activation in Older HIV-Infected Men.

Sophie Seang, Theodoros Kelesidis, Diana Huynh, Sangeun Park, Ardis A Moe, Judith S Currier, Jordan E Lake

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AIDS research and human retroviruses, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sophie Seang1 Infectious Diseases Department, AP-HP Pitié-Salpêtrière Hospital , Paris, France .
Theodoros Kelesidis3 Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine, University of California , Los Angeles, California.
Diana Huynh4 Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California , Los Angeles, California.
Sangeun Park3 Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine, University of California , Los Angeles, California.
Ardis A Moe3 Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine, University of California , Los Angeles, California.
Judith S Currier3 Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine, University of California , Los Angeles, California.
Jordan E Lake5 University of Texas Health Science Center at Houston , Houston, Texas.
University of California, Los Angeles · USThe University of Texas Health Science Center at Houston · US

Funding

Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANTON, PETER A · 1991 to 2018
$39.9M
UCLA OLDER AMERICANS INDEPENDENCE CENTERP30AG028748 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI REUBEN, DAVID B. · 2006 to 2017
$9.8M
Targeting early instigators of vascular inflammation to prevent and/or delay vascular aging in chronic treated HIVR01AG059502 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI KELESIDIS, THEODOROS · 2018 to 2022
$2.0M
Inflammation, Fibrosis and End-Organ Disease in HIV-Infected AdultsK23AI110532 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LAKE, JORDAN E · 2014 to 2018
$937k
Oxidized HDL in the intersection of HIV, immune activation and atherosclerosisK08AI108272 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KELESIDIS, THEODOROS · 2013 to 2017
$915k
Elucidating the impact of molecular signatures of immune senescence on aging in chronic treated HIVR03AG059462 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KELESIDIS, THEODOROS · 2018 to 2019
$156k
NIAID NIH HHS K08 AI108272NIAID NIH HHS K23 AI110532NIAID NIH HHS P30 AI028697NIA NIH HHS P30 AG028748NIA NIH HHS R01 AG059502NIA NIH HHS R03 AG059462
6 · The paper itself

Abstract

Endothelial progenitor cells (EPCs) repair damaged vascular endothelium, and low circulating EPC levels have been associated with cardiovascular disease (CVD). CD34

Indexed as

Age FactorsAtherosclerosisEndothelial Progenitor CellsEndothelium, VascularFlow CytometryHIVHIV InfectionsHumansInflammationLeukocytes, MononuclearMacrophage ActivationMaleMiddle AgedPilot ProjectsRisk Factorsendothelial progenitor cellsHIVinflammation

Identifiers

PMID29226690
PMCPMC5771525
OpenAlexW2983800485

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.